Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease

• by Jocelyn X. Jiang, Artur Shvetcov, Nicole Fewings, Prudence Gatt, Suat Dervish, Justin Y Garber, Matthew Silsby, Alessandro F Fois, Stephen Duma, Sushil Bandodkar, Sudarshini Ramanathan, Andrew Bleasel, Bryne John, Ian B Hickie, Elizabeth M Scott, Anthony Harris, Ming-Wei Lin, Caitlin A. Finney, David A. Brown

• May 4, 2026

Can Biomarkers Refine Psych Dx?

Emerging evidence suggests biologic signals may predict treatment response and improve outcomes.

• by Jamie Ducharme

• March 17, 2026

• 7 min

Urine Markers May Aid Psych Diagnosis

Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.

• by Andrea Surnit

• May 15, 2026

• 5 min

Plasma pTau217 Cutoffs for Clinical Use

Researchers assess how biological factors influence plasma biomarker interpretation for amyloid detection.

• by Kathryn Wighton

• February 4, 2026

• 4 min